TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 16, No. 1 January 4, 2010
(The next issue will be on January 15, 2010)
__________________________________________________________
TRIGGER is also available by RSS Feed:
http://feeds.feedburner.com/blogspot/glro
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None submitted for this issue.
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1BYJPJ6cwgn-2mmGgUP9v48/
Alehagen U, Dahlstrom U, and Lindahl TL (2009) Low plasma concentrations of coagulation factors II, VII and XI indicate increased risk among elderly with symptoms of heart failure. Blood Coagul Fibrinolysis
http://www.ncbi.nlm.nih.gov/pubmed/20040856
Castoldi E, Simioni P, Tormene D, Rosing J, and Hackeng TM (2009) Hereditary and acquired protein S deficiencies are associated with low TFPI levels in plasma. J Thromb Haemost
http://www.ncbi.nlm.nih.gov/pubmed/20002538
Fischer M, Sperling C, Tengvall P, and Werner C (2009) The ability of surface characteristics of materials to trigger leukocyte tissue factor expression. Biomaterials
http://www.ncbi.nlm.nih.gov/pubmed/20035991
Franchini M, Montagnana M, Favaloro EJ, and Lippi G (2009) The bidirectional relationship of cancer and hemostasis and the potential role of anticoagulant therapy in moderating thrombosis and cancer spread. Semin Thromb Hemost 35:644-653.
http://www.ncbi.nlm.nih.gov/pubmed/20013531
Gaud G, Iochmann S, Guillon-Munos A, Brillet B, Petiot S, et al. (2009) TFPI-2 silencing increases tumour progression and promotes metalloproteinase 1 and 3 induction through tumour-stromal cell interactions. J Cell Mol Med
http://www.ncbi.nlm.nih.gov/pubmed/20015200
Girolami A, Tezza F, Scandellari R, Vettore S, and Girolami B (2010) Associated prothrombotic conditions are probably responsible for the occurrence of thrombosis in almost all patients with congenital FVII deficiency. Critical review of the literature. J Thromb Thrombolysis
http://www.ncbi.nlm.nih.gov/pubmed/20044773
Halabian R, Fathabad ME, Masroori N, Roushandeh AM, Saki S, Amirizadeh N, Najafabadi AJ, Gharehbaghian A, and Roudkenar MH (2009) Expression and purification of recombinant human coagulation factor VII fused to a histidine tag using Gateway technology. Blood Transfus 7:305-312.
http://www.ncbi.nlm.nih.gov/pubmed/20011642
Hao J, Li W, Zou P, Li Q, Xia L, and You Y (2009) Expressions of tissue factor and tissue factor pathway inhibitor in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. J Huazhong Univ Sci Technolog Med Sci 29:697-700.
http://www.ncbi.nlm.nih.gov/pubmed/20037809
Hirasaki Y, Suematsu Y, Yasuda T, and Tajima K (2010) Thromboelastometry to guide recombinant activated factor VII therapy for postoperative refractory intracranial bleeding. Anesth Analg 110:261-262.
http://www.ncbi.nlm.nih.gov/pubmed/20023190
Juchem G, Weiss DR, Gansera B, Kemkes BM, Mueller-Hoecker J, and Nees S (2009) Pericytes in the macrovascular intima: possible physiological and pathogenetic impact. Am J Physiol Heart Circ Physiol
http://www.ncbi.nlm.nih.gov/pubmed/20023125
Kenet G, Stenmo CB, Blemings A, Wegert W, Goudemand J, Krause M, Schramm W, Kirchmaier C, and Martinowitz U (2009) Intra-patient variability of thromboelastographic parameters followingandadministration of recombinant activated factor VII in haemophilia patients. Thromb Haemost
http://www.ncbi.nlm.nih.gov/pubmed/20024491
Kirkel D, Lin TW, Fu SW, Dlott JS, Sahud MA, McCaffrey T, and Rickles FR (2009) Asymptomatic factor VII deficiency: Gene analysis and structure-function relationships. Blood Coagul Fibrinolysis
http://www.ncbi.nlm.nih.gov/pubmed/20040857
Krikun G, Hu Z, Osteen K, Bruner-Tran KL, Schatz F, et al. (2009) The immunoconjugate "icon" targets aberrantly expressed endothelial tissue factor causing regression of endometriosis. Am J Pathol
http://www.ncbi.nlm.nih.gov/pubmed/20042667
Lauritzen BP, Viuff DP, Tranholm MP, and Ezban MP (2009) rFVIIa and NN1731 reduce bleeding in hydroxyethyl starch hemodiluted rabbits. J Trauma
http://www.ncbi.nlm.nih.gov/pubmed/20032791
Levy JH, Dutton RP, Hemphill JC, III, Shander A, Cooper D, Paidas MJ, Kessler CM, Holcomb JB, and Lawson JH (2009) Multidisciplinary approach to the challenge of hemostasis. Anesth Analg
http://www.ncbi.nlm.nih.gov/pubmed/20007735
Luyendyk JP, Sullivan BP, Guo GL, and Wang R (2010) Tissue factor-deficiency and protease activated receptor-1-deficiency reduce inflammation elicited by diet-induced steatohepatitis in mice. Am J Pathol 176:177-186.
http://www.ncbi.nlm.nih.gov/pubmed/20008134
Muller F, Mutch NJ, Schenk WA, Smith SA, Esterl L, Spronk HM, Schmidbauer S, Gahl WA, Morrissey JH, and Renne T (2009) Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell 139:1143-1156.
http://www.ncbi.nlm.nih.gov/pubmed/20005807
Nadir Y, Henig I, Naroditzky I, Paz B, Vlodavsky I, and Brenner B(2009) Involvement of Heparanase in early pregnancy losses. Thromb Res
http://www.ncbi.nlm.nih.gov/pubmed/20031192
Persson E, Bolt G, Steenstrup TD, and Ezban M (2009) Recombinant coagulation factor VIIa - from molecular to clinical aspects of a versatile haemostatic agent. Thromb Res
http://www.ncbi.nlm.nih.gov/pubmed/20006996
Sioulis A, Malindretos P, Makedou A, Makris P, and Grekas D (2009) Coagulation factors as biological risk markers of endothelial dysfunction. Association with the thrombotic episodes of chronic hemodialysis patients. Hippokratia 13:237-241.
http://www.ncbi.nlm.nih.gov/pubmed/20011089
Solovey A, Kollander R, Milbauer LC, Abdulla F, Chen Y, Kelm RJ, Jr., and Hebbel RP (2010) Endothelial nitric oxide synthase and nitric oxide regulate endothelial tissue factor expression in vivo in the sickle transgenic mouse. Am J Hematol 85:41-45.
http://www.ncbi.nlm.nih.gov/pubmed/20029945
Stefanovic B, Stefanovic B, Mijatovic S, Radenkovic D, Popovic N, Sijacki A, and Lackovic V (2009) Use of recombinant factor VIIa in the treatment of massive retroperitoneal bleeding due to severe necrotizing pancreatitis. Vojnosanit Pregl 66:928-932.
http://www.ncbi.nlm.nih.gov/pubmed/20017427
Tang Z, Geng G, Huang Q, Xu G, Hu H, Chen J, and Li J (2009) Expression of Tissue Factor Pathway Inhibitor 2 in human pancreatic carcinoma and its effect on tumor growth, invasion, and migration in vitro and in vivo. J Surg Res
http://www.ncbi.nlm.nih.gov/pubmed/20018303
Wang B, Chen J, Santiago FS, Janes M, Kavurma MM, Chong BH, Pimanda JE, and Khachigian LM (2009) Phosphorylation and acetylation of Histone H3 and autoregulation by early growth response 1 Mediate Interleukin 1{beta} induction of early growth response 1 transcription. Arterioscler Thromb Vasc Biol
http://www.ncbi.nlm.nih.gov/pubmed/20018936
Zee RY, Glynn RJ, Cheng S, Steiner L, Rose L, and Ridker PM (2009) An evaluation of candidate genes of inflammation and thrombosis in relation to the risk of venous thromboembolism: The Women's Genome Health Study. Circ Cardiovasc Genet 2:57-62.
http://www.ncbi.nlm.nih.gov/pubmed/20031567
Zhou ZQ, Deng Z, Wang WD, and Yang F (2009) [Dynamic changes of plasma tissue factor and tissue factor pathway inhibitor-1 and their clinical significance in patients with multiple traumas.]. Nan Fang Yi Ke Da Xue Xue Bao 29:2501-2503.
http://www.ncbi.nlm.nih.gov/pubmed/20034913
____________________________________________________
ABOUT TRIGGER
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
